LONG-TERM EFFECTS OF INTERLEUKIN-2 ON CD4 CELL COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

被引:4
作者
RAMACHANDRAN, RV
KATZENSTEIN, D
MERIGAN, TC
机构
[1] Center for AIDS Research, Division of Infectious Diseases, Stanford, CA
关键词
D O I
10.1093/infdis/170.4.1044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1044 / 1046
页数:3
相关论文
共 6 条
[1]  
KOVACS JA, 1993, 33RD INT C ANT AG CH
[2]   A PHASE-I STUDY OF INTERFERON-ALPHA-2B IN COMBINATION WITH INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
SCHNITTMAN, SM ;
VOGEL, S ;
BASELER, M ;
LANE, HC ;
DAVEY, RT .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05) :981-989
[3]  
SCHWARTZ DH, 1991, J ACQ IMMUN DEF SYND, V4, P11
[4]  
SCHWARZ TL, 1990, NEURON, V2, P119
[5]   EFFICACY OF LOW-DOSES OF THE POLYETHYLENE-GLYCOL DERIVATIVE OF INTERLEUKIN-2 IN MODULATING THE IMMUNE-RESPONSE OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
TEPPLER, H ;
KAPLAN, G ;
SMITH, K ;
CAMERON, P ;
MONTANA, A ;
MEYN, P ;
COHN, Z .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) :291-298
[6]   SAFETY AND EFFICACY OF POLYETHYLENE-GLYCOL MODIFIED INTERLEUKIN-2 AND ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - A PHASE I-II STUDY [J].
WOOD, R ;
MONTOYA, JG ;
KUNDU, SK ;
SCHWARTZ, DH ;
MERIGAN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) :519-525